EUVIMEDEUVIMED entdecken
Crossref

Family Matters: Germline Testing in Thoracic Cancers

Feighanne Hathaway, Renato Martins, Steven Sorscher, Aleksandra Bzura, Frank Dudbridge, Dean A Fennell iD

American Society of Clinical Oncology Educational Book · 2023

DOI: 10.1200/edbk_389956 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Society of Clinical Oncology Educational Book, 2023. Verfasst von Feighanne Hathaway und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Section of Hematology/Oncology, The University of Chicago Comprehensive Cancer Center, Chicago, IL. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma, Mesothelioma, Malignant. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most thoracic cancers arise via a series of stepwise somatic alterations driven by a well-defined carcinogen (ie, tobacco or asbestos for lung cancer and mesothelioma, respectively). A small proportion can emerge on a background of pathogenic germline variants (PGVs), which have the property of heritability. In general, PGVs may be initially suspected on the basis of the presence of specific clinical features. Such gene × environment interactions significantly increase the risk of developing lung cancer (1.5- to 3.2-fold). PGVs have been discovered involving the actionable driver oncogene, epidermal growth factor receptor (EGFR), with an EGFR T790M PGV rate of 0.3%-0.9% in the nonsquamous non–small-cell lung cancer subtype. Its appearance during routine somatic DNA sequencing in those patients who have not had a previous tyrosine kinase inhibitor should raise suspicion. In patients with sporadic mesothelioma, BAP1 is the most frequently mutated tumor driver, with a PGV rate between 2.8% and 8%, associated with a favorable prognosis. BAP1 PGVs accelerate mesothelioma tumorigenesis after asbestos exposure in preclinical models and may be partly predicted by clinical criteria. At present, routine germline genetic testing for thoracic cancers is not a standard practice. Expert genetic counseling is, therefore, required for patients who carry a PGV. Ongoing studies aim to better understand the natural history of patients harboring PGVs to underpin future cancer prevention, precise counseling, and cancer management with the goal of improving the quality and length of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Non-Small-Cell LungMesotheliomaMesothelioma, MalignantAsbestosHumansErbB ReceptorsMutationTumor Suppressor ProteinsProtein Kinase InhibitorsGerm-Line MutationGerm CellsGenetic Predisposition to Disease

Substanzen

ErbB ReceptorsTumor Suppressor ProteinsProtein Kinase InhibitorsAsbestos

Autor:innen und Institutionen

  • Department of Medicine, Section of Hematology/Oncology, The University of Chicago Comprehensive Cancer Center, Chicago, IL.
  • Department of Hematology, Oncology, Palliative Care, Virginia Commonwealth University, Richmond, VA.
  • Biotheranostics, Inc, San Diego, CA.
  • The University of Leicester, Leicester, United Kingdom.
  • University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.

ORCID-Profile: Dean A Fennell

Zitieren

APA

Hathaway, F., Martins, R., Sorscher, S., Bzura, A., Dudbridge, F., & Fennell, D. A. (2023). Family Matters: Germline Testing in Thoracic Cancers. American Society of Clinical Oncology Educational Book. https://doi.org/10.1200/edbk_389956

Vancouver

Hathaway F, Martins R, Sorscher S, Bzura A, Dudbridge F, Fennell DA. Family Matters: Germline Testing in Thoracic Cancers. American Society of Clinical Oncology Educational Book. 2023. doi:10.1200/edbk_389956

BibTeX
@article{Hathaway2023,
  author = {Hathaway, Feighanne and Martins, Renato and Sorscher, Steven and Bzura, Aleksandra and Dudbridge, Frank and Fennell, Dean A},
  title = {Family Matters: Germline Testing in Thoracic Cancers},
  journal = {American Society of Clinical Oncology Educational Book},
  year = {2023},
  doi = {10.1200/edbk_389956}
}
Kostenlos starten →